BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 7479231)

  • 1. [Comparison of treatment effects with an angiotensin converting enzyme inhibitor--lisinopril and a calcium blocker--nifedipine retard on urinary albumin excretion in patients with non-complicated essential hypertension].
    Widecka K; CelibaƂa R; Czekalski S
    Pol Arch Med Wewn; 1995 Feb; 93(2):135-42. PubMed ID: 7479231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS.
    Leoncini G; Martinoli C; Viazzi F; Ravera M; Parodi D; Ratto E; Vettoretti S; Tomolillo C; Derchi LE; Deferrari G; Pontremoli R
    Nephron; 2002 Feb; 90(2):169-73. PubMed ID: 11818701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term effect of nifedipine GITS and lisinopril on subclinical organ damage in patients with essential hypertension.
    Pontremoli R; Viazzi F; Ravera M; Leoncini G; Berruti V; Bezante GP; Del Sette M; Deferrari G
    J Nephrol; 2001; 14(1):19-26. PubMed ID: 11281339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium antagonist in hypertensive, macroproteinuric diabetic patients: a randomised double-blind study.
    O'Donnell MJ; Rowe BR; Lawson N; Horton A; Gyde OH; Barnett AH
    J Hum Hypertens; 1993 Aug; 7(4):333-9. PubMed ID: 8410924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of successful hypertension control by manidipine or lisinopril on albuminuria and left ventricular mass in diabetic hypertensive patients with microalbuminuria.
    Fogari R; Mugellini A; Zoppi A; Lazzari P; Destro M; Rinaldi A; Preti P
    Eur J Clin Pharmacol; 2005 Aug; 61(7):483-90. PubMed ID: 16021438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
    Salako BL; Finomo FO; Kadiri S; Arije A; Olatosin AO
    Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension and non-insulin-dependent diabetes. A comparison between an angiotensin-converting enzyme inhibitor and a calcium antagonist.
    Crepaldi G; Carraro A; Brocco E; Adezati L; Andreani D; Bompiani G; Brunetti P; Fedele D; Giorgino R; Giustina G
    Acta Diabetol; 1995 Oct; 32(3):203-8. PubMed ID: 8590792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of combination therapy on regression of left ventricular hypertrophy in cases with hypertension.
    Boydak B; Nalbantgil S; Yilmaz H; Zoghi M; Ozerkan F; Nalbantgil I; Onder R
    Saudi Med J; 2004 Dec; 25(12):1975-8. PubMed ID: 15711679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors related to the occurrence of microalbuminuria during antihypertensive treatment in essential hypertension.
    Redon J; Rovira E; Miralles A; Julve R; Pascual JM
    Hypertension; 2002 Mar; 39(3):794-8. PubMed ID: 11897766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine.
    Agardh CD; Garcia-Puig J; Charbonnel B; Angelkort B; Barnett AH
    J Hum Hypertens; 1996 Mar; 10(3):185-92. PubMed ID: 8733038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The natriuretic effect of nifedipine gastrointestinal therapeutic system remains despite the presence of mild-to-moderate renal failure.
    Campo C; Garcia-Vallejo O; Barrios V; Lahera V; Manero M; Esteban E; Rodicio JL; Ruilope LM
    J Hypertens; 1997 Dec; 15(12 Pt 2):1803-8. PubMed ID: 9488243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of lisinopril and nitrendipine on urinary albumin excretion and renal function in patients with mild to moderate essential hypertension.
    Ogawa Y; Haneda T; Hirayama T; Ide H; Obara A; Maruyama J; Morimoto H; Tanaka H; Kato J; Hayakawa T; Hasebe N; Kikuchi K
    Hypertens Res; 2000 Nov; 23(6):607-12. PubMed ID: 11131273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of angiotensin converting enzyme inhibitors and calcium antagonists on atrial natriuretic peptide release and action and on albumin excretion rate in hypertensive insulin-dependent diabetic patients.
    Fioretto P; Frigato F; Velussi M; Riva F; Muollo B; Carraro A; Brocco E; Cipollina MR; Abaterusso C; Trevisan M
    Am J Hypertens; 1992 Nov; 5(11):837-46. PubMed ID: 1457087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of pentoxifylline with angiotensin converting enzyme inhibitors produces an additional reduction in microalbuminuria in hypertensive type 2 diabetic patients.
    Harmankaya O; Seber S; Yilmaz M
    Ren Fail; 2003 May; 25(3):465-70. PubMed ID: 12803510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of sodium excretion in human hypertension: long-term effects of calcium antagonist and angiotensin converting enzyme inhibitor.
    Coruzzi P; Musiari L; Mossini GL; Novarini A
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):920-5. PubMed ID: 7687717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study Group.
    BMJ; 1991 Jan; 302(6770):210-6. PubMed ID: 1998761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
    Jerums G; Allen TJ; Campbell DJ; Cooper ME; Gilbert RE; Hammond JJ; O'Brien RC; Raffaele J; Tsalamandris C;
    Diabet Med; 2004 Nov; 21(11):1192-9. PubMed ID: 15498085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparisons of long-term effects of lisinopril vs nifedipine vs conventional therapy in the treatment of mild-to-moderate hypertension in patients with chronic obstructive pulmonary disease.
    Lin M; Yang YF; Lee D; Chiang HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jun; 57(6):392-400. PubMed ID: 8803300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of lisinopril and nifedipine GITS increases blood pressure control compared with single drugs in essential hypertensive patients.
    Taddei S; Omboni S; Ghiadoni L; Caiazza A; Fogari R; Innocenti P; Porcellati C; Giovannetti R; Corradi L; Mancia G; Salvetti A
    J Cardiovasc Pharmacol; 2003 Apr; 41(4):579-85. PubMed ID: 12658059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy of lisinopril and nifedipine retard in essential hypertension: a double-blind, placebo-controlled trial.
    Richardson PJ; Meany TB; Johnston GD; Kondowe G; Grimmer SF; Breckenridge AM
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S96-8. PubMed ID: 2455154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.